Lv1
50 积分 2020-05-19 加入
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
28天前
已完结
Intratumoral T cell activation kills tumors regardless of T cell specificity
29天前
已完结
Oral Gut-Restricted Targeted Therapy for IBD: A Pipeline Review
1个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
1个月前
已完结
Liver abscess formation after transarterial chemoembolization in patients with hepatocellular carcinoma: a multicentre retrospective study (CHANCE 2407)
1个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
FRI-081 Transcatheter arterial chemoembolization combined with immune checkpoint inhibitors plus molecular targeted therapy after 125I irradiation stent placement in patients with hepatocellularcarcinoma and mainportalvein tumor thrombosis (PATENCY II)
1个月前
已关闭
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
4个月前
已完结
Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses
4个月前
已完结
Characteristics and Evolution of Extraintestinal Manifestations Associated with Ulcerative Colitis after Proctocolectomy
5个月前
已完结
皖公网安备34019202002308
